DCM
AGN

Driehaus Capital Management’s Allergan plc AGN Stock Holding History

Driehaus Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,200
Closed -$9K – 653
2016
Q2 		$9K Buy
+2,200
New +$507K ﹤0.01% 544

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Driehaus Capital Management's AGN Position: Q2 2020 in Review

Driehaus Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 100,902 shares — an estimated $17.9M sold.

Driehaus Capital Management first reported a position in AGN in Q1 2014 and held it in 14 quarters. The position peaked at $50.6M in Q1 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Driehaus Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Driehaus Capital Management sold 100,902 Allergan plc shares in Q2 2020, an estimated $17.9M.
  • Driehaus Capital Management first reported a position in Allergan plc in Q1 2014 and held it in 14 quarters.
  • Driehaus Capital Management's Allergan plc position peaked at $50.6M in Q1 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Driehaus Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.